VWR (VWR) Announces Acquisition of BioArra and Reliable Biopharmaceutical

November 3, 2016 6:12 AM EDT
Get Alerts VWR Hot Sheet
Trade VWR Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

VWR (Nasdaq: VWR) announced the acquisition of two companies, Reliable Biopharmaceutical and BioArra.

Reliable Biopharmaceutical, a manufacturer of high quality active pharmaceutical ingredients (APIs) and high purity ingredients (HPIs) such as cGMP excipients and advanced intermediates for the biopharmaceutical industry, enhances VWR's growing custom chemical and biochemical manufacturing portfolio. Reliable Biopharmaceutical offers highly-flexible, scalable and solution oriented production ranging from small batch clinical manufacturing to full scale commercial production. Based in St. Louis, Missouri and founded in 1968, Reliable Biopharmaceutical is a key supplier for many pharmaceutical, biopharmaceutical, diagnostic and cosmetic companies.

BioArra, a leading producer of U.S. origin serum-based products for use in research and production, strengthens our support to cellular science customers. Founded in 2008 and headquartered in Eagleville, Pennsylvania, BioArra produces semi-processed serum from various USDA approved supplier locations.

"BioArra and Reliable Biopharmaceutical greatly complement our previous acquisitions," said Manuel Brocke-Benz, President and CEO of VWR. "Aligned with our overall mergers and acquisitions strategy, these acquisitions continue to broaden our capabilities to provide value-added services and high quality products to our customers."

Financial details of this acquisition remain confidential.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Comments, Mergers and Acquisitions

Related Entities

Definitive Agreement

Add Your Comment